Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. hyscreen

HYscreen

A fast, cost-effective breath analysis technology for Helicobacter pYlori screening at both large and small scale.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 HYscreen project word cloud

Explore the words cloud of the HYscreen project. It provides you a very rough idea of what is the project "HYscreen" about.

commercially    nitrogen    final    asia    costly    entrapment    innovation    incidence    secondary    urea    invasive    optimization    absorption    doors    treatment    offers    infection    savings    business    feasibility    biopsies    lower    helicobacter    too    lymphoma    respectively    expensive    simpler    usa    ulceration    detects    validation    bedfont    ammonia    population    ultimately    aesthetics    healthcare    c12    breath    simplicity    consequently    accuracy    66    rapid    endoscopies    ltd    close    global    cancer    unnecessary    gastric    sampling    oxide    exhaled    affordable    quicker    shorten    thermal    inconvenient    avoiding    impetus    programs    market    plan    primary    biomarker    answering    give    diagnostics    scientific    prototype    hyscreen    bill    duodenal    diagnostic    protection    billion    ulcers    diagnosis    care    preventing    clinical    reduce    portable    fast    realized    cheaper    monitoring    pylori    time    though    air    sensor    convenience    solution    infections    device    optimizing    solutions    oxidizer    decisions    link    expertise    mouthpiece    trials    screening    tests   

Project "HYscreen" data sheet

The following table provides information about the project.

Coordinator		 Bedfont Scientific Limited 

Organization address
address: Station Yard, Station Road
city: Maidstone
postcode: ME17 1JA
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country United Kingdom [UK]
 Project website https://www.bedfont.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    Bedfont Scientific Limited UK (Maidstone) coordinator 50˙000.00

Map

 Project objective

The increasing incidence of Helicobacter (H.) pylori infections and their close link with gastric cancer, gastric lymphoma, duodenal and gastric ulceration, give impetus to the H. pylori diagnostics market. Existing solutions are too costly, inconvenient and invasive; have a long analysis time or need technical expertise to analyse. Bedfont Scientific Ltd offers a portable H. pylori diagnostic device, HYscreen, which detects ammonia in exhaled air as a biomarker for H. pylori. It has a rapid diagnosis, higher accuracy, lower cost, greater simplicity and convenience. It has the following innovation features: a mouthpiece breath entrapment sampling system, a thermal oxidizer and a Nitrogen Oxide (NO) sensor. This solution is aimed at primary and secondary care in Europe and USA and population screening programs in Asia, answering the call for a cheaper, quicker and simpler monitoring device. This will lead to improved clinical decisions that will facilitate early treatment of the infection, preventing H pylori related cases of gastric cancer and gastric or duodenal ulcers. Consequently, Europe-wide and global savings of up to €1.5 billion and €5.66 billion respectively will be realized by avoiding unnecessary endoscopies, biopsies, expensive H. pylori tests and the healthcare bill from H. pylori-related conditions. Ultimately, HYscreen will open doors for fast and affordable population wide screening. The test will use cheaper C12 urea, though work still needs to be done to make it commercially available. There is a challenge to shorten the thermal oxidizer system for better aesthetics and to reduce ammonia absorption. In Phase 1, we study the feasibility of optimizing the thermal oxidizer system, the use and optimization of C12 urea, protection of the product and the detailed business plan. Phase 2 will produce the final product from the prototype along with the validation steps and clinical trials.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HYSCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HYSCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More